Follow Me

Facebook LinkedIn Twitter youtube

Why Replace ICD-9?

Cancer Registrars have been using ICD-10 mortality codes for some time and we are familiar with coding and standards changes.  But, what is the “inside scoop” on why are ICD-9 codes are being replaced?  Here are some quick facts on what is happening in the industry.       

ICD-9-CM is a diagnostic and procedural classification system originally developed in the 1970’s.  As you might expect, its use has surpassed the original design and ICD-9 is no longer effective.  It simply cannot be stretched or updated any further to support 21st century medicine and healthcare.      

United States is the only industrial nation that has not upgraded its morbidity classification system.  By upgrading to ICD-10 we will improve our ability to monitor and respond to international health events, increase the value of theUS’s investment in SNOMED-CT®, and help provider organizations to achieve better benefits from the electronic health record (EHR). 

Briefly, ICD-9: 

  • Does not have adequate specificity and detail.
  • Is running out of capacity and its limited structural design cannot accommodate new advances in medicine, medical technology, or the rapidly growing need for quality data.
  • Is obsolete and no longer reflects current knowledge of disease processes, medical terminology or 21st century practices of medicine.
  • Impedes the use of a standardized system needed to compare costs and outcomes from different medical technologies and specialties.
  • Cannot support theUnited States’ transition to an interoperable health data exchange format.  

In summary, replacing the ICD-9 system with ICD-10 will help us to better maintain clinical data comparability with the rest of the world regarding conditions and diseases that require healthcare services.  ICD-10 makes it easier, and this directly affects cancer registrars, to share disease and mortality data during these critical times for public health.  

Cancer Registrars are already asking what the “ripple effect” will be for them.  The answer is simple, we don’t know yet.  Perhaps there will be change, but until ICD-10 is fully implemented the cancer registrar would be better served by developing an understanding of what is needed to analyze and report accurate and quality data in the 21st century and adopting a mindset that welcomes expanded use of cancer registry data and patient care outcomes.

To learn more about ICD-10 visit the American Health Information Management Association (AHIMA) website by clicking here.  Check back to our website for future posts about what is happening with ICD-10 and other planned training events such as webinars, white paper summaries and more.  

If you find this post helpful, add a comment below and tell us why!

——————–

Michele Webb creator of  http://www.RegistryMindset.com the cancer registrar’s best online resource, is a nationally recognized, certified cancer registrar, committed to Cancer Registry leadership and professional education as a coach, mentor, motivational speaker and author.  You have permission to repost this article as long as do not alter it in any way and give a link back and credit to the author and this URL.   

 

Hematopoietic & Lymphoid Project Update

SEER released an update to the desktop version of Hematopoietic and Lymphoid Neoplasm Case Reportability and Coding Manual version 1.6.2 today.  If you are a working cancer registrar or cancer registry student and have not already downloaded this update you may want to consider doing so right away.

This online manual contains the instructions and data collection rules for hematopoietic and lymphoid neoplasms that went into effect on January 1, 2010.  Remember the older version we dubbed “the red book.”  This online database replaces the “red book” and contains more information, including the MP/H rules. 

When you download and install, don’t forget to sign up for email updates so that as new versions are released you are notified right away so you keep your references up-to-date.  This is an incredibly valuable resource that every cancer registrar must have!

TELL US YOUR STORY … how have you used, or how has the SEER hematopoietic online database helped you?  Scroll down and post a short comment and help another cancer registrar today.

http://www.RegistryMindset.com.  Michele Webb is committed to cancer registry leadership and to making a difference in the lives of cancer registrars worldwide.  She is a nationally recognized, certified cancer registrar (CTR), a motivational speaker, author and educator.  You have permission to repost this article as long as you do not alter it in any way, give credit tot he author and link back to this article on this website.

New Hematopoietic & Lymphoid Rules

Beginning January 1, 2010 new reportability requirements for the data collection and reporting of hematopoietic and lymphoid neoplasms go into effect. The Hematopoietic Working Group (SEER) have developed the new rules and an electronic database that cancer registrars will be able to download and use.

Casefinding for heme and lymphoid neoplasms can be confusing given the variation in how physicians and pathologists document the diagnosis and treatment process for their patients. However, the cancer registrar can now take advantage of some new educational presentations developed by SEER to understand the requirements more fully.

By clicking here you will be redirected to the SEER website and links to the educational presentations. Presentations have been approved for CEU credits and additional presentations will be posted by SEER through December, 2009.

Tell you friends and fellow registrars about this new program!